The mRNA and protein levels of SLC2A1 (GLUT1) are higher in GBM than in the normal brain tissues, as indicated by GEPIA and The Human Protein Atlas immunohistochemical analyses, respectively. Here, SLC2A1 is linked to glioblastoma.